Authors:
Cocquyt, V
Van Belie, S
Reinhardt, RR
Decramer, MLA
O'Brien, M
Schellens, JHM
Borms, M
Verbeke, L
Van Aelst, F
De Smet, M
Carides, AD
Eldridge, K
Gertz, BJ
Citation: V. Cocquyt et al., Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis, EUR J CANC, 37(7), 2001, pp. 835-842
Authors:
Campos, D
Pereira, JR
Reinhardt, RR
Carracedo, C
Poli, S
Vogel, C
Martinez-Cedillo, J
Erazo, A
Wittreich, J
Eriksson, LO
Carides, AD
Gertz, BJ
Citation: D. Campos et al., Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone, J CL ONCOL, 19(6), 2001, pp. 1759-1767
Authors:
Navari, RM
Reinhardt, RR
Gralla, RJ
Kris, MG
Hesketh, PJ
Khojasteh, A
Kindler, H
Grote, TH
Pendergrass, K
Grunberg, SM
Carides, AD
Gertz, BJ
Citation: Rm. Navari et al., Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptorantagonist, N ENG J MED, 340(3), 1999, pp. 190-195